NUCLEOLIN and acute myeloid leukemia: The stratification using NCL expression levels allows to discriminate two groups in elderly AML patients (> 60 years)–low and high expression-related groups of NCL expression associated in TCGA series with median survivals of approximately 15 or 6 months, respectively.